Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SD
Drug holidays in patients with unresectable and metastatic melanoma after an objective response or prolonged disease stabilization during ITH result in durable control of the disease, particularly in patients with complete response.
Authors
- Paweł Teterycz (ORCID: https://orcid.org/0000-0001-7304-714X)
- Krzysztof Ostaszewski (ORCID: https://orcid.org/0000-0002-9679-0523)
- Natasza Kempa-Kamińska (ORCID: https://orcid.org/0000-0002-1347-7778)
- Marcin Ziętek (ORCID: https://orcid.org/0000-0002-7890-3483)
- Katarzyna Kozak (ORCID: https://orcid.org/0000-0002-3225-422X)
- Anna Malgorzata Czarnecka (ORCID: https://orcid.org/0000-0002-2107-3810)
- Łukasz Galus (ORCID: https://orcid.org/0000-0002-9515-1834)
- Katarzyna Galwas
- Grażyna Kamińska‐Winciorek (ORCID: https://orcid.org/0000-0002-9810-4945)
- Piotr Rutkowski (ORCID: https://orcid.org/0000-0002-8920-5429)
- Robert Dziura (ORCID: https://orcid.org/0000-0001-6177-6695)
- Bożena Cybulska-Stopa (ORCID: https://orcid.org/0000-0002-0975-850X)
- Piotr Błoński (ORCID: https://orcid.org/0009-0003-4289-7741)
- Jacek Mackiewicz (ORCID: https://orcid.org/0000-0002-2556-5900)
- Magdalena Zielińska (ORCID: https://orcid.org/0000-0001-7388-3092)
Institutions
- Wrocław University of Science and Technology (PL)
- Poznan University of Medical Sciences (PL)
- Medical University of Warsaw (PL)
- Wroclaw Medical University (PL)
- Greater Poland Cancer Center (PL)
- National Institute of Oncology (HU)
- Holy Cross University (PL)
- Lublin Oncology Center (PL)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- AGH University of Krakow (PL)
Publication Details
- Journal
- Targeted Oncology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1007/s11523-025-01156-2
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05